Form 8-K Celldex Therapeutics, For: Nov 07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Celldex (CLDX) Tops Q3 EPS by 4c
November 7, 2016 4:02 PM ESTCelldex (NASDAQ: CLDX) reported Q3 EPS of ($0.29), $0.04 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $850 thousand.
For earnings history and earnings-related data on Celldex (CLDX) click here.
... More


